Flutemetamol F-18 Patent Expiration
Flutemetamol F-18 is Used for imaging internal structures and organs for diagnostic purposes. It was first introduced by Ge Healthcare
Flutemetamol F-18 Patents
Given below is the list of patents protecting Flutemetamol F-18, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vizamyl | US7270800 | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition | Sep 03, 2025 | Ge Healthcare |
| Vizamyl | US7351401 | Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition |
Jan 24, 2023
(Expired) | Ge Healthcare |
| Vizamyl | US8236282 | Benzothiazole derivative compounds, compositions and uses |
May 21, 2024
(Expired) | Ge Healthcare |
| Vizamyl | US8691185 | Benzothiazole derivative compounds, compositions and uses |
Jan 24, 2023
(Expired) | Ge Healthcare |
| Vizamyl | US8916131 | Radiopharmaceutical composition | Sep 16, 2028 | Ge Healthcare |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Flutemetamol F-18's patents.
Latest Legal Activities on Flutemetamol F-18's Patents
Given below is the list recent legal activities going on the following patents of Flutemetamol F-18.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 25 Jan, 2024 | US8236282 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 19 May, 2022 | US8916131 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 22 Sep, 2021 | US8691185 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 23 Jan, 2020 | US8236282 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Sep, 2019 | US7351401 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 07 Mar, 2019 | US7270800 |
| Post Issue Communication - Certificate of Correction | 27 Nov, 2018 | US7270800 |
| Post Issue Communication - Certificate of Correction | 14 Nov, 2018 | US8236282 |
| Post Issue Communication - Certificate of Correction | 07 Nov, 2018 | US8691185 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 25 Jun, 2018 | US8916131 |